Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by Don2018on Oct 28, 2019 8:19am

142 Views

Post# 30275682

RE:CEO = One Million Warrants Cashed

Pareto8020 wrote: Looks like Howard cashed in a million warrants @ .25. Smart move - hopefully all is done and signals move higher around corner.

https://www.canadianinsider.com/node/7?menu_tickersearch=SBM+%7C+Sirona+Biochem

The encouraging thing is he only sold enough of the resulting common shares to pay for exercising most of the warrants. And not all, he left $50,000 of his own money in, as well as 550,000 shares.

So maybe he has faith that the share price will continue to rise? :o)

Bullboard Posts

Canadian government to fund Electric Royalties portfolio property